These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 5076072)

  • 1. Dipyridamole (persantin) and warfarin in the treatment of glomerulonephritis.
    First MR; Goldberg B; Abrahams C
    S Afr Med J; 1972 Jun; 46(25):848-9. PubMed ID: 5076072
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction of dipyridamole with anticoagulants in the treatment of glomerulonephritis.
    Kalowski S; Kincaid-Smith P
    Med J Aust; 1973 Jul; 2(4):164-6. PubMed ID: 4741342
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapidly progressive glomerulonephritis: treatment with combined immunosuppression and anticoagulation with arvin.
    Segasothy M; Kong CT; Morad Z; Suleiman AB; Phang KS
    Singapore Med J; 1986 Oct; 27(5):422-7. PubMed ID: 3823948
    [No Abstract]   [Full Text] [Related]  

  • 4. Are anticoagulants beneficial in the treatment of rapidly progressive glomerulonephritis?
    Cameron JS
    Proc Eur Dial Transplant Assoc; 1973; 10(0):57-90. PubMed ID: 4606240
    [No Abstract]   [Full Text] [Related]  

  • 5. Prospective trial of warfarin and dipyridamole in patients with membranoproliferative glomerulonephritis.
    Zimmerman SW; Moorthy AV; Dreher WH; Friedman A; Varanasi U
    Am J Med; 1983 Dec; 75(6):920-7. PubMed ID: 6359877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of mesangiocapillary glomerulonephritis in children with combined immunosuppression and anticoagulation.
    Chapman SJ; Cameron JS; Chantler C; Turner D
    Arch Dis Child; 1980 Jun; 55(6):446-51. PubMed ID: 7436483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of cyclophosphamide, warfarin and dipyridamole in idiopathic membranous glomerulonephritis.
    Murphy BF; McDonald I; Fairley KF; Kincaid-Smith PS
    Clin Nephrol; 1992 May; 37(5):229-34. PubMed ID: 1606772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of triple therapy on the progression of mesangial proliferative glomerulonephritis.
    Woo KT; Edmondson RP; Yap HK; Wu AY; Chiang GS; Lee EJ; Pwee HS; Lim CH
    Clin Nephrol; 1987 Feb; 27(2):56-64. PubMed ID: 3549083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin.
    Woo KT; Lee GS
    Clin Nephrol; 1991 Apr; 35(4):184. PubMed ID: 1855324
    [No Abstract]   [Full Text] [Related]  

  • 10. The treatment of glomerulonephritis.
    Kincaid-Smith P
    Aust N Z J Med; 1980 Jun; 10(3):340-5. PubMed ID: 6931575
    [No Abstract]   [Full Text] [Related]  

  • 11. Benefit of cyclophosphamide therapy in IgA nephritis may have been obscured by warfarin-related nephropathy in the randomized trials in which warfarin and dipyridamole were used in combination with cyclophosphamide.
    Brodsky SV; Rovin BH; Hebert LA
    Nephrol Dial Transplant; 2012 Feb; 27(2):475-7. PubMed ID: 21948859
    [No Abstract]   [Full Text] [Related]  

  • 12. Controlled trial of dipyridamole and low-dose warfarin in patients with IgA nephritis with renal impairment.
    Lee GS; Woo KT; Lim CH
    Clin Nephrol; 1989 May; 31(5):276. PubMed ID: 2661066
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe fibrin and crescent glomerulonephritis: clinical and morphological aspects of 33 patients.
    Mathew TH; Kincaid-Smith P
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):727-34. PubMed ID: 4803314
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapidly progressive glomerulonephritis treated with anticoagulants.
    Arieff AI; Pinggera WF
    Arch Intern Med; 1972 Jan; 129(1):77-84. PubMed ID: 4550298
    [No Abstract]   [Full Text] [Related]  

  • 15. [Glomerulonephritis therapy. Immunosuppression or coagulation inhibitors - a comparison].
    Schmitt E; Sinn W; Lakner V; Ratner M; Tomilina N
    Z Gesamte Inn Med; 1980 Aug; 35(15):Suppl 45-8. PubMed ID: 7467565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of anti-thrombotic therapy in renal disease.
    Kincaid-Smith P
    Scand J Haematol Suppl; 1979; 34():83-9. PubMed ID: 384508
    [No Abstract]   [Full Text] [Related]  

  • 17. [Glomerulonephritis and anticoagulants: therapy with dipyridamole in lupoid glomerulonephritis].
    Barlattani M; Guglielmi G; Mammarella A
    Clin Ter; 1972 Nov; 63(3):251-7. PubMed ID: 4644529
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of kidney arteriosclerosis: heparin, dipyridamole, warfarin, and plasma exchange.
    Kincaid-Smith P
    Transplant Proc; 1987 Aug; 19(4 Suppl 5):82-4. PubMed ID: 3303574
    [No Abstract]   [Full Text] [Related]  

  • 19. The natural history and treatment of mesangiocapillary glomerulonephritis.
    Kincaid-Smith P
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():591-609. PubMed ID: 4536441
    [No Abstract]   [Full Text] [Related]  

  • 20. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: a two-year prospective trial.
    Walker RG; Yu SH; Owen JE; Kincaid-Smith P
    Clin Nephrol; 1990 Sep; 34(3):103-7. PubMed ID: 2225560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.